NeueHealth Past Earnings Performance
Past criteria checks 0/6
NeueHealth's earnings have been declining at an average annual rate of -31%, while the Healthcare industry saw earnings growing at 5.6% annually. Revenues have been declining at an average rate of 14.5% per year.
Key information
-31.0%
Earnings growth rate
12.1%
EPS growth rate
| Healthcare Industry Growth | 8.5% |
| Revenue growth rate | -14.5% |
| Return on equity | n/a |
| Net Margin | -46.1% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Bright Health Group: Stock Price Has Been Too Heavily Beaten Down
Jan 19Bright Health Group expects FY23 revenue to be below consensus
Jan 10Bright Health receives non-compliance notice from NYSE
Dec 12Bright Health Group reports Q3 mixed earnings; revises Fy22 guidance
Nov 09Bright Health narrows footprint to only offer Medicare Advantage in California, Florida
Oct 11Analysts Have Been Trimming Their Bright Health Group, Inc. (NYSE:BHG) Price Target After Its Latest Report
Aug 13
Bright Health Group Takes Cost Actions To Effect Turnaround
Jul 21Bright Health Group: Examining A Dumpster Fire
Jan 04Revenue & Expenses Breakdown
How NeueHealth makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 1,105 | -510 | 302 | 0 |
| 31 Dec 23 | 1,161 | -563 | 315 | 0 |
| 30 Sep 23 | 2,756 | -1,078 | 615 | 0 |
| 30 Jun 23 | 2,680 | -660 | 606 | 0 |
| 31 Mar 23 | 871 | -447 | 337 | 0 |
| 31 Dec 22 | 751 | -521 | 354 | 0 |
| 30 Sep 22 | -1,031 | -373 | 9 | 0 |
| 30 Jun 22 | -145 | -513 | 233 | 0 |
| 31 Mar 22 | 819 | -450 | 415 | 0 |
| 31 Dec 21 | 1,513 | -330 | 527 | 0 |
| 30 Sep 21 | 3,427 | -534 | 924 | 0 |
| 30 Jun 21 | 2,700 | -293 | 712 | 0 |
| 31 Mar 21 | 1,883 | -266 | 539 | 0 |
| 31 Dec 20 | 515 | -161 | 221 | 0 |
| 31 Dec 19 | 281 | -125 | 180 | 0 |
| 31 Dec 18 | 131 | -63 | 96 | 0 |
Quality Earnings: NEUE is currently unprofitable.
Growing Profit Margin: NEUE is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NEUE is unprofitable, and losses have increased over the past 5 years at a rate of 31% per year.
Accelerating Growth: Unable to compare NEUE's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NEUE is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (15.1%).
Return on Equity
High ROE: NEUE's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.